flunisolide has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonanno, A; Bousquet, J; Bruno, A; Di Giorgi, R; Gagliardo, R; Profita, M; Riccobono, L; Vignola, AM | 1 |
| Bergeron, C; Dhanda, R; Gotfried, M; Hamid, Q; Hauber, HP; Ludwig, MS; Newman, K; Servi, RJ | 1 |
1 trial(s) available for flunisolide and transforming growth factor beta
| Article | Year |
|---|---|
Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide.
Topics: Actins; Adult; Anti-Asthmatic Agents; Asthma; Bronchi; Collagen; Drug Combinations; Female; Fluocinolone Acetonide; Humans; Male; Muscle, Smooth; Respiratory Function Tests; Severity of Illness Index; Transforming Growth Factor beta; Treatment Outcome | 2005 |
1 other study(ies) available for flunisolide and transforming growth factor beta
| Article | Year |
|---|---|
In vitro effects of flunisolide on MMP-9, TIMP-1, fibronectin, TGF-beta1 release and apoptosis in sputum cells freshly isolated from mild to moderate asthmatics.
Topics: Adult; Apoptosis; Asthma; Fibronectins; Fluocinolone Acetonide; Humans; Matrix Metalloproteinase 9; Middle Aged; Sputum; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |